← Back to Search

Automated Health Coaching for Type 2 Diabetes (GODART-P&F Trial)

N/A
Recruiting
Led By Mohanraj Thirumalai, PHD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
≥18 years of age
Diagnosis of T2DM
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

GODART-P&F Trial Summary

This trial will test a low-cost AI-assisted lifestyle intervention for diabetes in rural areas, which is delivered via landline phone. It will provide knowledge to develop an optimal intervention package in the future.

Who is the study for?
This trial is for adults over 18 with Type 2 Diabetes, who speak and read English, have a doctor's approval to join, and HbA1c levels between 7% to 10.5%. It's not for those pregnant or planning pregnancy, in another diabetes study, on insulin treatment, with recent renal failure or major heart events.Check my eligibility
What is being tested?
The study tests an AI-assisted lifestyle change program aimed at controlling blood sugar in rural areas via regular phone service. Participants receive either automated or human health coaching weekly with varying reward systems to see which method works best.See study design
What are the potential side effects?
Since the interventions involve lifestyle modifications through coaching rather than medication, typical medical side effects are not expected. However, participants may experience stress or frustration if they find it difficult to adhere to the program.

GODART-P&F Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been diagnosed with type 2 diabetes.

GODART-P&F Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Hemoglobin A1C level between screening and 6 months

GODART-P&F Trial Design

4Treatment groups
Experimental Treatment
Group I: Arm 4Experimental Treatment2 Interventions
Fixed Reward + Weekly human coaching
Group II: Arm 3Experimental Treatment2 Interventions
Fixed Reward + Weekly automated coaching
Group III: Arm 2Experimental Treatment2 Interventions
Adaptive Rewards + Weekly human coaching
Group IV: Arm 1Experimental Treatment2 Interventions
Adaptive Rewards + Weekly automated coaching

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,590 Previous Clinical Trials
2,281,554 Total Patients Enrolled
Mohanraj Thirumalai, PHDPrincipal InvestigatorUniversity of Alabama at Birmingham
Tapan Mehta, PHDPrincipal InvestigatorUniversity of Alabama at Birmingham

Media Library

Arm 4 Clinical Trial Eligibility Overview. Trial Name: NCT05344859 — N/A
Type 2 Diabetes Research Study Groups: Arm 4, Arm 2, Arm 3, Arm 1
Type 2 Diabetes Clinical Trial 2023: Arm 4 Highlights & Side Effects. Trial Name: NCT05344859 — N/A
Arm 4 2023 Treatment Timeline for Medical Study. Trial Name: NCT05344859 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are actively participating in this research?

"Affirmative. According to information provided on clinicaltrials.gov, this medical trial commenced recruiting on July 12th 2023 and was last updated two days later. A total of 108 patients are being sought from one site for participation."

Answered by AI

Are there any remaining vacancies in this clinical trial?

"Yes, clinicaltrials.gov confirms that this project is recruiting patients with the trial having been posted on July 12th and modified most recently on July 14th."

Answered by AI
~8 spots leftby Jun 2024